These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14629913)

  • 1. Localized morphea: a rare adverse effect of valproic acid.
    Ferzli GT; El-Tal Ael-K; Kibbi AG; Mikati MA
    Pediatr Neurol; 2003 Sep; 29(3):253-5. PubMed ID: 14629913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized morphea: a side effect of valproate sodium?
    Goihman-Yahr M; Leal G; Essenfeld-Yahr E
    Arch Dermatol; 1980 Jun; 116(6):621. PubMed ID: 6769395
    [No Abstract]   [Full Text] [Related]  

  • 3. Choroidal sclerosis in localized scleroderma (morphea en plaque).
    Milenkovic S; Petrovic L; Risimic D; Kosanovic-Jakovic N; Jaksic V; Djakovic Z; Stojkovic M; Risovic D; Ivankovic Lj; Ivancevic-Milenkovic M
    Ophthalmic Res; 2008; 40(2):101-4. PubMed ID: 18223304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleroderma and dentistry: Two case reports.
    Dixit S; Kalkur C; Sattur AP; Bornstein MM; Melton F
    J Med Case Rep; 2016 Oct; 10(1):297. PubMed ID: 27776552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris.
    Saleh Z; Arayssi T; Saleh Z; Ghosn S
    J Cutan Pathol; 2009 Oct; 36(10):1105-8. PubMed ID: 19602063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphea after bromocriptine therapy.
    Leshin B; Piette WW; Caplan RM
    Int J Dermatol; 1989 Apr; 28(3):177-9. PubMed ID: 2523364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphea associated with the use of adalimumab: a case report and review of the literature.
    Ramírez J; Hernández MV; Galve J; Cañete JD; Sanmartí R
    Mod Rheumatol; 2012 Aug; 22(4):602-4. PubMed ID: 22095405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear morphea presenting as acquired unilateral edema.
    Fiala KH; Wells MJ; Mullinax KA; Stetson CL; Paulger BR
    Pediatr Dermatol; 2007; 24(2):147-50. PubMed ID: 17461812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous morphea profunda.
    Su WP; Greene SL
    Am J Dermatopathol; 1986 Apr; 8(2):144-7. PubMed ID: 3717524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.
    Walker D; Susa JS; Currimbhoy S; Jacobe H
    J Am Acad Dermatol; 2017 Jun; 76(6):1124-1130. PubMed ID: 28285783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib.
    Rünger TM; Adami S; Benhamou CL; Czerwiński E; Farrerons J; Kendler DL; Mindeholm L; Realdi G; Roux C; Smith V
    J Am Acad Dermatol; 2012 Mar; 66(3):e89-96. PubMed ID: 21571394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous rosai-dorfman disease and morphea: coincidence or association?
    Chappell JA; Burkemper NM; Frater JL; Hurley MY
    Am J Dermatopathol; 2009 Jul; 31(5):487-9. PubMed ID: 19542928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized morphea: a case report.
    Payapvipapong K; Aunhachoke K
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S215-7. PubMed ID: 21280538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoscleroderma secondary to phytonadione (vitamin K1) injections.
    Pujol RM; Puig L; Moreno A; Pérez M; de Moragas JM
    Cutis; 1989 Apr; 43(4):365-8. PubMed ID: 2731442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear morphea with secondary cutaneous mucinosis.
    Chun SI; Cho NJ
    Am J Dermatopathol; 1992 Dec; 14(6):546-8. PubMed ID: 1471750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
    Ross SA; Sánchez JL; Taboas JO
    Am J Dermatopathol; 1990 Aug; 12(4):357-62. PubMed ID: 2393064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New side effect of TNF-alpha inhibitors: morphea.
    Stewart FA; Gavino AC; Elewski BE
    Skinmed; 2013; 11(1):59-60. PubMed ID: 23540081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.